FOLH1 and pachyonychia congenita: By considering the PSMA-avid prostatic lesions and the corresponding classification in the GS based on the biopsy, a SUVmax of 8.95 was analyzed by ROC analysis (p = 0.007) to differentiate between csPC and clinically insignificant PC (subgroup: csPCa) for 18F-PMSA with a sensitivity of 62%, a specificity of 85%, a PPV of 92%, and an accuracy of 67%.